Sort
15,440 grants matching “organoids”
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
$642,000Teresa K Woodruff · Northwestern University At Chicago · UH2 · FY2013 · ES
The miR-20/c-Myc/E2F Regulatory Axis is Critical for the Tumor Promoting Activity of Inflammatory Fibroblasts in Colitis-Associated Cancer
$641,811Emina Hui-Na Huang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$641,748Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2018 · AG
Establishing and Mimicking Patterning Mechanisms in the Distal Nephron Tubule and Kidney Organoid
$641,608Nils Olof Lindstrom · University Of Southern California · R01 · FY2025 · DK
Project 2: Splicing Dysregulation in Cancer
$641,584Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2024 · CA
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
$641,436Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2021 · AG
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
$641,436Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2024 · AG
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
$641,436Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2023 · AG
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
$641,436Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2022 · AG
Membrane repair boosted by caspase signaling
$641,385Edward A Miao · Duke University · R01 · FY2025 · AI
Systematic Identification and Phenotypic Characterization of causal genetic variants in Rare Disease-Associated Birth Defects
$641,122Scott T Younger · Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2025 · HD
Precision Medicine for Inherited Retinal Degenerations
$641,107Eric A Pierce · Massachusetts Eye And Ear Infirmary · R01 · FY2025 · EY
The role of tuft cells in norovirus pathogenesis
$641,093Craig Brian Wilen · Yale University · R01 · FY2021 · AI
Mechanisms of Ischemic Kidney Injury and Repair
$641,082Joseph Vincent Bonventre · Brigham And Women'S Hospital · R01 · FY2025 · DK
Systematic Identification and Phenotypic Characterization of causal genetic variants in Rare Disease-Associated Birth Defects
$641,067Scott T Younger · Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2023 · HD
Regulation of type II cells in the repair of alveolar epithelial injury
$641,027Yuru Liu · University Of Illinois At Chicago · R01 · FY2024 · HL
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
$640,945Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Precision Medicine for Inherited Retinal Degenerations
$640,774Eric A Pierce · Massachusetts Eye And Ear Infirmary · R01 · FY2024 · EY
Enteric virus exploitation of calcium signaling
$640,765Joseph M. Hyser · Baylor College Of Medicine · R01 · FY2025 · DK
Probing the Role of Integrator in Neuronal Function
$640,729Eric J Wagner · University Of Rochester · R01 · FY2025 · NS
Study the pathogenesis of neurological disorders using human neural cultures derived from patient peripheral blood CD34 cells
$640,650Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Metabolic reprogramming to boost the fitness of anti-tumor immunity against metastatic colon cancer
$640,583Semir Beyaz · Cold Spring Harbor Laboratory · R37 · FY2025 · CA
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$640,470Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Precision Medicine for Inherited Retinal Degenerations
$640,439Eric A Pierce · Massachusetts Eye And Ear Infirmary · R01 · FY2023 · EY
Impact of Circadian-Microbiome Interaction on the Gut-Pancreas Axis in Aging
$640,435Faraz Bishehsari · University Of Texas Hlth Sci Ctr Houston · U01 · FY2025 · AG